Your browser doesn't support javascript.
loading
Clinicopathological features and treatment outcome of oesophageal gastrointestinal stromal tumour (GIST): A large, retrospective multicenter European study.
Mohammadi, Mahmoud; IJzerman, Nikki S; Hohenberger, Peter; Rutkowski, Piotr; Jones, Robin L; Martin-Broto, Javier; Gronchi, Alessandro; Schöffski, Patrick; Vassos, Nikolaos; Farag, Sheima; Baia, Marco; Oosten, Astrid W; Steeghs, Neeltje; Desar, Ingrid M E; Reyners, An K L; van Sandick, J W; Bastiaannet, Esther; Gelderblom, Hans; Schrage, Yvonne.
Afiliação
  • Mohammadi M; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: m.mohammadi@lumc.nl.
  • IJzerman NS; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Hohenberger P; Division of Surgical Oncology & Thoracic Surgery, Mannheim University Medical Center, University of Heidelberg, Germany.
  • Rutkowski P; Maria Sklodowska-Curie National Research Institute of Oncology, Department of Soft Tissue/Bone Sarcoma and Melanoma, Warsaw, Poland.
  • Jones RL; The Royal Marsden NHS Foundation Trust / Institute of Cancer Research, London, UK.
  • Martin-Broto J; Medical Oncology Department, Virgen del Rocio University Hospital, Seville, Spain.
  • Gronchi A; Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Schöffski P; Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.
  • Vassos N; Division of Surgical Oncology & Thoracic Surgery, Mannheim University Medical Center, University of Heidelberg, Germany.
  • Farag S; Sarcoma Unit, The Royal Marsden NHS Foundation Trust, London, UK.
  • Baia M; Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Oosten AW; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Steeghs N; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Desar IME; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Reyners AKL; Department of Medical Oncology, University Medical Center Groningen, Groningen, the Netherlands.
  • van Sandick JW; Department of Surgical Oncology, Antoni van Leeuwenhoek - Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Bastiaannet E; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands; Department of Surgical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
  • Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.
  • Schrage Y; Department of Surgical Oncology, Antoni van Leeuwenhoek - Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Surgical Oncology, Leiden University Medical Center, Leiden, The Netherlands; European School of Soft Tissue Sarcoma Surgery, Amsterdam, the Netherlands.
Eur J Surg Oncol ; 47(8): 2173-2181, 2021 08.
Article em En | MEDLINE | ID: mdl-33895019
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Esofagoscopia / Esofagectomia / Tumores do Estroma Gastrointestinal / Mesilato de Imatinib / Antineoplásicos Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Esofagoscopia / Esofagectomia / Tumores do Estroma Gastrointestinal / Mesilato de Imatinib / Antineoplásicos Idioma: En Ano de publicação: 2021 Tipo de documento: Article